Health
Zentiva Romania 9-Month Net Profit Rises To RON37M
Pharmaceuticals company Zentiva Romania (SCD.RO) Thursday said its net profit rose 14.3% to 37.2 million lei (EUR8.4 million) in the first nine months, fueled by higher sales.
Biofarm 9-Month Sales Up 11% On Year To RON85.5M
Romanian pharmaceutical company Biofarm (BIO.RO) said Monday it registered sales of 85.5 million lei (EUR19.4 million) in the first nine months of 2013, up about 11% on the year, and 7% high...
Ropharma Sales Flat At RON307M In January-September
Sales of pharmaceutical company Ropharma Brasov (RPH.RO), owned by businessman Mihai Miron, remained flat on the year in January-September, at RON307.1 million (EUR69.6 million), and its net...
British Alliance Boots Acquires Full Control Over Romanian Farmexpert
British pharmaceutical giant Alliance Boots has acquired full control over Romanian pharmaceutical wholesaler Farmexpert, one of the largest companies on the local profile market, after purc...
Allianz Underwrote EUR136M On General Insurance In Romania In January-September
German insurance group Allianz underwrote general insurance premiums of EUR136 million in Romania in January-September, up 0.7% on the year, and doubled its operating profit to EUR4 million.
Terapia Ranbaxy Invests EUR6.6 Million In R&D Center
Terapia Ranbaxy, the largest generic drug producer in Romania, will invest 29.2 million lei (almost EUR6.6 million) in a research and development center in Cluj-Napoca (NW Romania) to make n...
Three New Public Hospitals In Bucharest Attract EUR80M Investments
No new public hospital has been built in Romania’s capital city Bucharest after the fall of communism in December 1989, but this year works have started on a new Foisor hospital and are ongo...
Terapia Ranbaxy 3Q Turnover Up 5%, To RON110M
Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, registered a growth of around 5% in turnover in the third quarter, to RON110 million (EUR24.7 millio...
Romanian Pharmaceutical Market Down 3.3% To RON2.79B In 3Q/2013
Romania’s pharmaceutical market fell 3.3% on the year to 2.79 billion lei (EUR0.62 billion) in the third quarter of 2013, according to market research company Cegedim Romania.